This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Dose-Dependent Interaction between Gemfibrozil and Repaglinide in Humans: Strong Inhibition of CYP2C8 with Subtherapeutic Gemfibrozil Doses, Drug Metabolism and Disposition, July 2011, American Society for Pharmacology & Experimental Therapeutics (ASPET),
DOI: 10.1124/dmd.111.040931.
You can read the full text:
The following have contributed to this page
